Analyst Ratings published Tuesday December 9th 2025

12/9/25	Initiated	Buy	X
A Agilent Goldman
$170
12/9/25	Initiated	Market Perform	X
AAL American Airlines BMO Capital Markets
$16.75
12/9/25	Reiterated	Buy	X
AAPL Apple Citigroup
$315 $330
12/9/25	Initiated	Buy	X
AER AerCap Truist
$159
12/9/25	Initiated	Peer Perform	X
AFRM Affirm Wolfe Research
12/9/25	Downgrades	Overweight Neutral	X
ALEX Alexander & Baldwin Piper Sandler
$21
12/9/25	Initiated	Equal Weight	X
ALGN Align Tech Barclays
$170
12/9/25	Initiated	Underweight	X
ALVO Alvotech Barclays
$5
12/9/25	Initiated	Equal Weight	X
AMPH Amphastar Pharmaceuticals Barclays
$30
12/9/25	Initiated	Overweight	X
AMRX Amneal Pharmaceuticals Barclays
$15
12/9/25	Downgrades	Buy Neutral	X
BABA Alibaba Arete
$172
12/9/25	Upgrades	Neutral Sec Outperform	X
BCE BCE Inc CIBC
12/9/25	Initiated	Equal Weight	X
BHC Bausch Health Barclays
$8
12/9/25	Initiated	Sell	X
BRKR Bruker Goldman
$40
12/9/25	Initiated	Overweight	X
CAH Cardinal Health Barclays
$243
12/9/25	Downgrades	Outperform Sec Perform	X
CIM Chimera Investment RBC Capital Mkts
$13
12/9/25	Upgrades	Sec Perform Outperform	X
CL Colgate-Palmolive RBC Capital Mkts
$88
12/9/25	Initiated	Overweight	X
COLL Collegium Pharmaceutical Barclays
$58
12/9/25	Initiated	Overweight	X
COR Cencora Barclays
$400
12/9/25	Initiated	Outperform	X
DAL Delta Air Lines BMO Capital Markets
$80
12/9/25	Initiated	Buy	X
DHR Danaher Goldman
$265
12/9/25	Initiated	Overweight	X
DOCS Doximity Barclays
$63
12/9/25	Initiated	Overweight	X
ELAN Elanco Animal Health Barclays
$30
12/9/25	Upgrades	Peer Perform Outperform	X
ETN Eaton Wolfe Research
$413
12/9/25	Downgrades	Eq Weight Underweight	X
FMC FMC Corp Barclays
$13
12/9/25	Initiated	Underweight	X
GDRX GoodRx Barclays
$3
12/9/25	Downgrades	Outperform Mkt Perform	X
GOGO Gogo William Blair
12/9/25	Initiated	Overweight	X
HIMS Hims & Hers Health Barclays
$48
12/9/25	Initiated	Overweight	X
HQY HealthEquity Barclays
$118
12/9/25	Initiated	Overweight	X
HSIC Henry Schein Barclays
$86
12/9/25	Initiated	Overweight	X
IDXX IDEXX Labs Barclays
$850
12/9/25	Downgrades	Buy Neutral	X
JD JD.com Arete
$32
12/9/25	Upgrades	Hold Buy	X
KEY KeyCorp TD Cowen
$24
12/9/25	Reiterated	Buy	X
KNX Knight-Swift TD Cowen
$53 $60
12/9/25	Initiated	Overweight	X
LFST LifeStance Health Group Barclays
$8
12/9/25	Initiated	Buy	X
LGND Ligand Pharma Citigroup
$270
12/9/25	Initiated	Market Perform	X
LUV Southwest Air BMO Capital Markets
$43
12/9/25	Upgrades	Neutral Buy	X
LYEL Lyell Immunopharma H.C. Wainwright
$45
12/9/25	Initiated	Overweight	X
MCK McKesson Barclays
$960
12/9/25	Initiated	Neutral	X
MTD Mettler-Toledo Goldman
$1475
12/9/25	Initiated	Buy	X
MU Micron HSBC Securities
$330
12/9/25	Downgrades	Buy Neutral	X
NCLH Norwegian Cruise Line Goldman
$21
12/9/25	Initiated	Buy	X
NRG NRG Energy UBS
12/9/25	Initiated	Overweight	X
NVST Envista Barclays
$24
12/9/25	Initiated	Underweight	X
OGN Organon Barclays
$7.50
12/9/25	Upgrades	Neutral Outperform	X
OTIS Otis Worldwide BNP Paribas Exane
$105
12/9/25	Resumed	Buy	X
PAG Penske Auto BofA Securities
$195
12/9/25	Reiterated	Market Perform	X
PAYX Paychex BMO Capital Markets
$140 $121
12/9/25	Initiated	Equal Weight	X
PCRX Pacira BioSciences Barclays
$27
12/9/25	Downgrades	Buy Neutral	X
PDD PDD Holdings Arete
$130
12/9/25	Initiated	Overweight	X
PGNY Progyny Barclays
$29
12/9/25	Initiated	Equal Weight	X
PHAT Phathom Pharmaceuticals Barclays
$16
12/9/25	Initiated	Overweight	X
PHR Phreesia Barclays
$26
12/9/25	Upgrades	Hold Buy	X
RELX RELX Deutsche Bank
12/9/25	Upgrades	Sec Perform Outperform	X
RPM RPM Inc RBC Capital Mkts
$132
12/9/25	Initiated	Neutral	X
RVTY Revvity Goldman
$105
12/9/25	Downgrades	Buy Sell	X
SLM Sallie Mae Compass Point
$23
12/9/25	Downgrades	Overweight Eq-Weight	X
SLM Sallie Mae Morgan Stanley
$31
12/9/25	Upgrades	Neutral Buy	X
SNPS Synopsys Rosenblatt
$560
12/9/25	Downgrades	Buy Neutral	X
SNY Sanofi Guggenheim
12/9/25	Initiated	Outperform	X
SRPT Sarepta Therapeutics Wedbush
$32
12/9/25	Initiated	Overweight	X
TARS Tarsus Pharmaceuticals Barclays
$100
12/9/25	Initiated	Equal Weight	X
TDOC Teladoc Barclays
$8.50
12/9/25	Initiated	Overweight	X
TEVA Teva Pharma Barclays
$35
12/9/25	Initiated	Buy	X
TMO Thermo Fisher Goldman
$685
12/9/25	Upgrades	Underperform Mkt Perform	X
TROX Tronox BMO Capital Markets
$6
12/9/25	Initiated	Outperform	X
UAL United Airlines BMO Capital Markets
$125
12/9/25	Initiated	Neutral	X
URBN Urban Outfitters Goldman
$83
12/9/25	Initiated	Overweight	X
VOR Vor Biopharma JP Morgan
$43
12/9/25	Downgrades	Outperform Peer Perform	X
VRT Vertiv Wolfe Research
12/9/25	Initiated	Overweight	X
VTRS Viatris Barclays
$15
12/9/25	Downgrades	Buy Neutral	X
WBD Warner Bros. Discovery Seaport Research Partners
12/9/25	Upgrades	Sec Perform Outperform	X
WVE Wave Life Sciences RBC Capital Mkts
$27
12/9/25	Initiated	Overweight	X
XERS Xeris Biopharma Barclays
$9
12/9/25	Initiated	Underweight	X
XRAY Dentsply Sirona Barclays
$12
12/9/25	Initiated	Equal Weight	X
ZTS Zoetis Barclays
$136